Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on September 4, 2025
The Ninth Circuit Orders California to Respond concerning its Mandatory DEI Indoctrination in Continuing Medical Education Courses, According to the Association of American Physicians and Surgeons
GlobeNewswire
·
September 4, 2025
TUCSON, Ariz., Sept. 04, 2025 (GLOBE NEWSWIRE) -- On September 2, the U.S. Court of Appeals for the Ninth Circuit ordered California to respond to a petition for rehearing challenging its diversity, equity, and inclusion (DEI) mandated inclusion in all …
NJ Healthy Aging Summit to Spotlight Opioid Safety and Alternatives for Older Adults
GlobeNewswire
·
September 4, 2025
ATLANTIC CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- A conference later this month will examine the keys to healthy aging and the challenges that prescribed opioids and opioid dependency pose to the older adult population. "NJ Healthy Aging Summit: Opioid …
Avania Strengthens Leadership Team with Appointment of Four New Executives
GlobeNewswire
·
September 4, 2025
BILTHOVEN, Netherlands and BOSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Avania, the leading global MedTech advisory and clinical development partner, is pleased to announce strategic leadership appointments of four distinguished executives. As the MedTech …
Inmedix® raises a record $44,689 to support kids with arthritis and autoimmune diseases at Seattle Children’s
EIN Presswire
·
September 4, 2025
This 9th Annual Golf Tournament takes aggregate funding support to over $210,000. NORMANDY PARK, WA, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- Seattle-based biotech/medtech Inmedix®, Inc. continued to support kids with arthritis and …
Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
GlobeNewswire
·
September 4, 2025
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today …
Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight
GlobeNewswire
·
September 4, 2025
New York, USA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight The colorectal surgical devices market is predicted to surge owing to the rising incidence of colorectal …
OPSEU/SEFPO and CUPE Ontario community and social services workers launch “Worth Fighting For” coordinated bargaining campaign at rally in Hamilton
GlobeNewswire
·
September 4, 2025
Hamilton, Ontario, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Today, hundreds of OPSEU/SEFPO and CUPE Ontario workers and labour allies rallied in Hamilton to demand immediate, long-term funding for community and social services; affirming their commitment to …
Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform
GlobeNewswire
·
September 4, 2025
NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK) -- Dear Shareholders, I'm writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth …
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation
GlobeNewswire
·
September 4, 2025
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation NANTES, France – September 4, 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) reaffirms its strategic commitment to value …
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur
GlobeNewswire
·
September 4, 2025
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur NANTES, France – 4 septembre 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) réaffirme, à l’approche de l’ …
Dr. Gregory Facemyer Scholarship Launches Nationwide Essay Contest for Aspiring Medical Doctors
GlobeNewswire
·
September 4, 2025
YOUNGSTOWN, Ohio, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Dr. Gregory Facemyer Scholarship for Medical Students officially opens its application cycle, inviting undergraduate students across the United States to submit original essays that explore the …
Legend Senior Living Welcomes Annalisa Hahn as Senior Vice President of Sales and Marketing
GlobeNewswire
·
September 4, 2025
WICHITA, Kan., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a nationally recognized senior living provider with more than 70 residences across seven states, is pleased to announce the appointment of Annalisa Hahn as Senior Vice President of …
Thailand LAB INTERNATIONAL 2025 Strengthens Thailand’s Role as a Regional Innovation Hub
EIN Presswire
·
September 4, 2025
Thailand LAB INTERNATIONAL 2025: Asia's leading science, health, and future food innovation hub. Uniting global experts …
AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland
GlobeNewswire
·
September 4, 2025
Latest progress from lead program Ampligen for the treatment of pancreatic cancer highlighted at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025); Presentation now available here Ampligen has …
Bay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease Solutions
GlobeNewswire
·
September 4, 2025
PORTOLA VALLEY, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the launch of Bay Area Lyme Ventures (Lyme Ventures), a bold new impact fund that is the first …
PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen
GlobeNewswire
·
September 4, 2025
-New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15-day treatment of Paxlovid ( …
Really Global Launches Global Mental Health Marketplace with 2000+ Search Filters Connecting Clients to Providers in 200+ Countries
GlobeNewswire
·
September 4, 2025
San Francisco, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Really Global today announced the launch of its comprehensive mental health marketplace that connects clients with therapists, psychologists, nurse practitioners, social workers, coaches, and mentors …
The University of Alabama and GATC Health Unveil Strategic Program to Accelerate Therapeutic Discovery and Development
GlobeNewswire
·
September 4, 2025
IRVINE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, today announced the launch of a strategic program with The University of …
Comprehensive Report on the Insurance For Against Covid-19 Market: Opportunities and Challenges
EIN Presswire
·
September 4, 2025
The Business Research Company's Insurance For Against Covid-19 Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 4, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For …
Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
GlobeNewswire
·
September 4, 2025
LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the execution of a new …